AddLife Investor Relations Material
Access more data
AddLife AB, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. AddLife's products are used in the development of cell therapies: cellular immunotherapy for autoimmune disease at institutions such as Scripps Research Institute Florida; clinical translation for Dystrophin gene therapy by partners such as Nationwide Children's Hospital; and phenotyping services for clinical researchers at Rush University Medical Center. It also offers products for biopharmaceutical development, including cell sorters from Abacus Biosystems; high-content screening plates for use in the drug discovery process; and automated microscope slide stainer products for automated image analysis and high content analysis. The company is based in Stockholm, Sweden.
Key slides for AddLife
Marvel-ous Reporting: Marvel’s Comic Inspired Reports
Shareholder reports are often considered tedious and dry. However, in the late 1980s and early 1990s, Marvel Comics revolutionized this perception by transforming its financial reports into captivating comic books.
8 Dec 2023
The Payments Value Chain: A Complex Ecosystem
The payments industry is a complex and dynamic field involving multiple key players. These include customers, merchants, issuers, acquirers, card networks, and various other entities together forming the payments value chain.
8 Dec 2023
NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023